Steven H. Stein - Nov 5, 2025 Form 4 Insider Report for INCYTE CORP (INCY)

Signature
/s/ Elizabeth Feeney, Attorney-In-Fact
Stock symbol
INCY
Transactions as of
Nov 5, 2025
Transactions value $
-$47,945
Form type
4
Date filed
11/7/2025, 04:01 PM
Previous filing
Jul 23, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Stein Steven H EVP & Chief Medical Officer 1801 AUGUSTINE CUT-OFF, WILMINGTON /s/ Elizabeth Feeney, Attorney-In-Fact 2025-11-07 0001673776

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INCY Common Stock Options Exercise $100K +1.19K +1.16% $83.83 104K Nov 5, 2025 Direct
transaction INCY Common Stock Options Exercise $287K +3K +2.88% $95.76 107K Nov 5, 2025 Direct
transaction INCY Common Stock Options Exercise $100K +1.04K +0.98% $95.76 108K Nov 5, 2025 Direct
transaction INCY Common Stock Sale -$535K -5.23K -4.84% $102.20 103K Nov 5, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INCY Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.19K -100% $0.00 0 Nov 5, 2025 Common Stock 1.19K $83.83 Direct F2
transaction INCY Non-Qualified Stock Option (right to buy) Options Exercise $0 -3K -100% $0.00 0 Nov 5, 2025 Common Stock 3K $95.76 Direct F3
transaction INCY Incentive Stock Option (right to buy) Options Exercise $0 -1.04K -100% $0.00 0 Nov 5, 2025 Common Stock 1.04K $95.76 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 This includes an aggregate of 100,327 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested.
F2 Beginning July 15, 2016, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
F3 Beginning January 7, 2016, options become exercisable in full on January 7, 2020.